购物车
- 全部删除
- 您的购物车当前为空
Substance P(1-7) TFA 是神经肽 P 物质 (SP) 的片段,具有抗伤害活性,通过脊髓 NMDA-NO 级联反应防止吗啡诱发的自发性疼痛行为,可用于研究神经系统疾病。
Substance P(1-7) TFA 是神经肽 P 物质 (SP) 的片段,具有抗伤害活性,通过脊髓 NMDA-NO 级联反应防止吗啡诱发的自发性疼痛行为,可用于研究神经系统疾病。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 266 | 现货 | |
5 mg | ¥ 619 | 现货 | |
10 mg | ¥ 993 | 现货 | |
25 mg | ¥ 2,320 | 现货 | |
50 mg | ¥ 3,450 | 现货 | |
100 mg | ¥ 4,890 | 现货 | |
200 mg | ¥ 6,790 | 现货 |
产品描述 | Substance P(1-7) TFA is a fragment of neuropeptide P (SP) with anti-nociceptive activity. It prevents morphine-induced spontaneous pain behavior through the spinal NMDA-NO cascade, and can be used in research on neurological diseases. |
体内活性 | 注射低剂量的Substance P(1-7) TFA(1.0-4.0 pM),并与SP或SP(5-11)(0.1 nM)同时使用,可显著抑制SP或SP(5-11)引发的厌恶行为。这些发现表明,内源性生成的Substance P(1-7)可能通过调控SP或SP(5-11)的作用在脊髓中发挥重要功能。[1] |
分子量 | 1014.06 |
分子式 | C43H66F3N13O12 |
CAS No. | 2828433-22-1 |
Smiles | C(C(O)=O)(F)(F)F.C([C@@H](NC(=O)[C@H]1N(C([C@H](CCCNC(=N)N)N)=O)CCC1)CCCCN)(=O)N2[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC3=CC=CC=C3)C(O)=O)=O)CCC(N)=O)=O)CCC(N)=O)=O)CCC2 |
存储 | keep away from moisture,keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | H2O: 40 mg/mL (39.45 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
H2O
|
评论内容